New Knowledge on How HIV Beats the Body's Early Immune Response

Article

Dr. Najla Nasr (left) with senior author Tony Cunningham. Courtesy of Westmead Institute for Medical Research

In an important step toward eradicating HIV-associated viral reservoirs, researchers at Sydney's Westmead Institute for Medical Research have identified how the HIV virus hijacks the innate immune system to facilitate its replication and spread, thus gaining a foothold infection in the body.

The findings, published in the Journal of Virology, show how HIV induces antiviral interferon stimulated genes in the absence of interferon production.

Lead author of the study, Dr. Najla Nasr, said it's like a prize fight, with both HIV and the body's immune response both fighting for supremacy: "When a person is infected with HIV, the virus infects immune cells and knocks out the body's interferon production; the first line of defense in our bodies. When interferon production is inhibited, the virus infects adjacent cells and spreads throughout the body. Surprisingly, we found that although HIV inhibits interferon production it also stimulates more than 20 antiviral interferon-stimulated genes (ISGs) in its key target cells. This is the largest effect yet shown by any individual virus. ISGs are critical for controlling virus infections. They provide the earliest protective response to counter invading pathogens, but paradoxically they can also contribute to virus persistence. For its own survival advantage, HIV induces these genes in order to survive and spread throughout the body."

Nasr said the ultimate goal of this research was to understand how these antiviral genes are induced and thus coming up with strategies to boost their expression so that the virus replication is not just slowed but completely stopped.

Source: Westmead Institute for Medical Research

Related Videos
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Related Content